SE452550B - Tablett med fordrojd frigoring av teofyllin - Google Patents

Tablett med fordrojd frigoring av teofyllin

Info

Publication number
SE452550B
SE452550B SE8102814A SE8102814A SE452550B SE 452550 B SE452550 B SE 452550B SE 8102814 A SE8102814 A SE 8102814A SE 8102814 A SE8102814 A SE 8102814A SE 452550 B SE452550 B SE 452550B
Authority
SE
Sweden
Prior art keywords
tablet
theophylline
tablet according
weight
hours
Prior art date
Application number
SE8102814A
Other languages
English (en)
Swedish (sv)
Other versions
SE8102814L (sv
Inventor
S T David
D Brooke
C E Gallian
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8102814L publication Critical patent/SE8102814L/
Publication of SE452550B publication Critical patent/SE452550B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8102814A 1980-05-06 1981-05-05 Tablett med fordrojd frigoring av teofyllin SE452550B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14742980A 1980-05-06 1980-05-06
US24978781A 1981-04-01 1981-04-01

Publications (2)

Publication Number Publication Date
SE8102814L SE8102814L (sv) 1981-11-07
SE452550B true SE452550B (sv) 1987-12-07

Family

ID=26844921

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102814A SE452550B (sv) 1980-05-06 1981-05-05 Tablett med fordrojd frigoring av teofyllin

Country Status (17)

Country Link
AT (1) AT380789B (enrdf_load_stackoverflow)
AU (1) AU549299B2 (enrdf_load_stackoverflow)
CA (1) CA1165241A (enrdf_load_stackoverflow)
CY (1) CY1368A (enrdf_load_stackoverflow)
DE (1) DE3117756A1 (enrdf_load_stackoverflow)
DK (1) DK155976C (enrdf_load_stackoverflow)
FI (1) FI811356A7 (enrdf_load_stackoverflow)
FR (1) FR2484253A1 (enrdf_load_stackoverflow)
GB (1) GB2078518B (enrdf_load_stackoverflow)
HK (1) HK4288A (enrdf_load_stackoverflow)
IE (1) IE51157B1 (enrdf_load_stackoverflow)
IT (1) IT1209867B (enrdf_load_stackoverflow)
KE (1) KE3722A (enrdf_load_stackoverflow)
LU (1) LU83342A1 (enrdf_load_stackoverflow)
NL (1) NL8102168A (enrdf_load_stackoverflow)
SE (1) SE452550B (enrdf_load_stackoverflow)
SG (1) SG30987G (enrdf_load_stackoverflow)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547358A (en) * 1980-05-06 1985-10-15 Mead Johnson & Company Sustained release tablet containing at least 95 percent theophylline
US4503031A (en) * 1982-12-17 1985-03-05 Glassman Jacob A Super-fast-starting-sustained release tablet
HU187215B (en) * 1983-01-26 1985-11-28 Egyt Gyogyszervegyeszeti Gyar Method for producing pharmaceutical product of high actor content and prolonged effect
US4753945A (en) * 1986-02-19 1988-06-28 Eye Research Institute Of Retina Foundation Stimulation of tear secretion with phosphodiesterase inhibitors
FR2595945B1 (fr) * 1986-03-19 1990-01-19 Doms Laboratoires Comprime-retard de theophylline a base de p.v.c., et son procede de preparation
USD557612S1 (en) * 2006-04-10 2007-12-18 Parfums Christian Dior Flask for a cosmetic product

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE636568A (enrdf_load_stackoverflow) * 1961-01-31
DE1228029C2 (de) * 1964-05-09 1973-05-17 Merck Ag E Verfahren zur Herstellung von Tabletten durch Pressen von Pulvergemischen ohne vorhergehende Granulation
US3723614A (en) * 1971-01-06 1973-03-27 Ciba Geigy Ag Maltese-cross scored tablet
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion

Also Published As

Publication number Publication date
GB2078518B (en) 1984-04-11
KE3722A (en) 1987-04-30
DK200181A (da) 1981-11-07
GB2078518A (en) 1982-01-13
FI811356L (fi) 1981-11-07
AT380789B (de) 1986-07-10
DE3117756C2 (enrdf_load_stackoverflow) 1992-11-26
CA1165241A (en) 1984-04-10
FR2484253B1 (enrdf_load_stackoverflow) 1983-06-03
IE810989L (en) 1981-11-06
AU549299B2 (en) 1986-01-23
ATA202081A (de) 1985-12-15
FI811356A7 (fi) 1981-11-07
DK155976C (da) 1989-10-30
NL8102168A (nl) 1981-12-01
SE8102814L (sv) 1981-11-07
AU7020581A (en) 1981-11-12
CY1368A (en) 1987-08-07
IT1209867B (it) 1989-08-30
DE3117756A1 (de) 1982-04-29
FR2484253A1 (fr) 1981-12-18
SG30987G (en) 1987-07-17
IE51157B1 (en) 1986-10-15
DK155976B (da) 1989-06-12
HK4288A (en) 1988-01-29
LU83342A1 (fr) 1982-01-20
IT8148406A0 (it) 1981-05-06

Similar Documents

Publication Publication Date Title
US4465660A (en) Sustained release tablet containing at least 95 percent theophylline
US4375468A (en) Constant order release aspirin composition and method of treating arthritis
US3488418A (en) Sustained relief analgesic composition
EP0231826B1 (en) Theophylline sustained release tablet
Solaiman et al. Application of general multilevel factorial design with formulation of fast disintegrating tablets containing croscaremellose sodium and Disintequick MCC-25
Alburyhi et al. Formulation, Development and Evaluation of Acalypha Fruticosa Extract Tablets Delivery System as an Advanced Phytotherapy Approach for Controlling Diabetes
FI96095C (fi) Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi
JPS63107917A (ja) イブプロフエン徐放性製剤およびその製造方法
US4547358A (en) Sustained release tablet containing at least 95 percent theophylline
CA1140466A (en) Pharmaceutical compositions
EP0025686A2 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
SE452550B (sv) Tablett med fordrojd frigoring av teofyllin
CN113712982B (zh) 一种预防或治疗非酒精性脂肪肝、肥胖症的组合物及制备方法和应用
RU2124899C1 (ru) Способ получения противоязвенного средства
GB2164556A (en) Sustained release pharmaceutical tablet of theophylline and production process therefor
Sahoo et al. Formulation and evaluation of orodispersible tablets of granisetron hydrochloride using plantago ovate as natural superdisintegrants
RU2207116C1 (ru) Лекарственное средство в виде таблеток на основе экстракта пустырника
Tambe Formulation and Evaluation of Paracetamol Effervescent Tablet
Paul et al. FORMULATION AND EVALUATION OF METFORMIN HYDROCHLORIDE ORO-DISPERSIBLE TABLETS
Bhosale et al. Formulation and Evaluation of Metformin HCL Gastroretentive Floating Sustained Released Tablet
Tablets et al. PrPRZ-METFORMIN
JP3653747B2 (ja) コデイン含有カプセル剤
CN120152707A (zh) 用于治疗疼痛的对乙酰氨基酚和萘普生
Babu Development and optimization of gliclazide sublingual tablets by using co-processed excipient to treat type II diabetes
RU20030U1 (ru) Таблетка

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8102814-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8102814-4

Format of ref document f/p: F